Literature DB >> 8568259

Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro.

M Gröger1, G Sarmay, E Fiebiger, K Wolff, P Petzelbauer.   

Abstract

Immune complexes are thought to be the major cause of cutaneous necrotizing vasculitis, but the mechanism of immune complex targeting to specific vessels is largely unknown. In myelomonocytic cells, immune complex binding and receptor-mediated endocytosis are mediated by Fc gamma R. We asked whether dermal microvascular endothelial cells (DMEC) express Fc gamma Rs. In cryostat sections of normal human skin, mAb IV.3 or AT10, both recognizing CD32 (Fc gamma RII), localizes to the luminal surface of DMEC of the superficial but not of the deep vascular plexus. All DMEC do not express CD16 (Fc gamma RIII) or CD64 (Fc gamma RI) molecules. Adult skin-derived DMEC in culture express CD32 (Fc gamma RII) molecules, as measured by FACS, but are negative for CD16 or CD64. HUVEC, tested for comparison, do not express CD16, 32, or 64 proteins. By reverse-transcriptase PCR and subsequent Southern blot analysis, the isoform of the CD32 molecule expressed on DMEC is determined as Fc gamma RIIa. HUVEC do not contain Fc gamma RIIa or Fc gamma RIIb mRNA. In DMEC, Fc gamma RIIa cross-linking results in immediate intracellular free Ca2+ ([Ca2+]i) concentration fluxes and in rapid internalization of the occupied receptors. We conclude that DMEC are equipped with fully functional Fc gamma RIIa molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568259

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  [Leukocytoclastic vasculitis].

Authors:  C Sunderkötter; J Roth; G Bonsmann
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

2.  Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.

Authors:  Daniel Chargelegue; Pascal M W Drake; Patricia Obregon; Alessandra Prada; Neil Fairweather; Julian K-C Ma
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.

Authors:  A Birkmann; K Mahr; A Ensser; S Yağuboğlu; F Titgemeyer; B Fleckenstein; F Neipel
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice.

Authors:  Dag K Skovseth; Takeshi Yamanaka; Per Brandtzaeg; Eugene C Butcher; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

6.  Were monocytes responsible for initiating the cytokine storm in the TGN1412 clinical trial tragedy?

Authors:  G P Sandilands; M Wilson; C Huser; L Jolly; W A Sands; C McSharry
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

7.  C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC.

Authors:  S Xiao; C Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

8.  Cytokine profiles of cultured microvascular endothelial cells from the human intestine.

Authors:  E M Nilsen; F E Johansen; F L Jahnsen; K E Lundin; T Scholz; P Brandtzaeg; G Haraldsen
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

9.  Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.

Authors:  Harald Langeggen; Knut Erik Berge; Egil Johnson; Geir Hetland
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

10.  Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells.

Authors:  Herwig Peter Moll; Harald Freudenthaler; Anna Zommer; Elisabeth Buchberger; Christine Brostjan
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.